Showing all 24 results
Cabergoline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Compressed, Micro-Dose Tablet, packed in high-barrier Alu-Alu blister strips or specialized glass vials to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Cabergoline USP/Ph.Eur. 0.5 mg The Standard Specialty Anchor: The definitive therapeutic unit for managing prolactin-related infertility and pituitary tumors. Excipients Proprietary Matrix Micro-Gram Content Uniformity: Engineered utilizing Geometric Dilution techniques to ensure every 0.5 mg tablet contains the exact clinical dose across the entire batch. Dapagliflozin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive propanediol monohydrate active ingredient.
Active Ingredient Strength Primary Clinical Function Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 5 mg The Titration & Hepatic Anchor: The definitive starting dose utilized for patients with severe hepatic impairment or those at high risk for volume depletion (hypotension). Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur. 10 mg The Cardio-Renal Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily maintenance of Heart Failure, CKD, and Type 2 Diabetes. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Crospovidone / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing Strict Low-Humidity Granulation to prevent the highly sensitive API from degrading during compression, sealed with an impenetrable film-coat to block environmental moisture and ensure rapid gastric dissolution) *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28-Tablet Calendar Packs (Optimized specifically for strict chronic cardio-renal dispensing regimens).
Desmopressin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extreme Microdose Peptide Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical stability of the fragile acetate salt.
Active Ingredient Strength Primary Clinical Function Desmopressin Acetate USP/Ph.Eur.
(Equivalent to Desmopressin base)0.1 mg The Titration & Pediatric Anchor: The definitive starting dose utilized for primary nocturnal enuresis in children or baseline control of Central Diabetes Insipidus. Desmopressin Acetate USP/Ph.Eur. 0.2 mg The Maintenance Macrodose: High-efficacy therapeutic payload utilized for severe, refractory polyuria and nocturia in adults. Excipients Lactose Monohydrate / Potato Starch / Povidone K-30 / Magnesium Stearate Diluent / Disintegrant / Binder / Lubricant (Engineered specifically utilizing Strict Geometric Dilution to ensure the microscopic peptide payload is flawlessly uniform, manufactured under stringent low-moisture conditions to prevent hydrolytic degradation of the fragile peptide bonds) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic endocrine dispensing regimens).
Ethinyestradiol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hazard-Shielded Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the synthetic steroidal API.
Active Ingredient Strength Primary Clinical Function Ethinylestradiol USP/Ph.Eur. 0.05 mg (50 mcg) The Endocrinology Standard: The definitive micro-dose engineered specifically for female hypogonadism, primary ovarian failure, and strictly monitored estrogen replacement. Ethinylestradiol USP/Ph.Eur. 1 mg The Palliative Oncology Macrodose: Massive therapeutic payload utilized strictly for the aggressive hormonal suppression of advanced, inoperable prostate or breast cancer. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Heavy Film-Coating (Engineered specifically to form an impenetrable physical barrier over the tablet core. This completely seals the potent steroidal API, ensuring absolute safety for handlers and guaranteeing zero cross-contamination in the facility) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrine and oncology dispensing regimens).
Glibenclamide, Metformin & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.
Active Ingredient Strength Primary Clinical Function Glibenclamide USP/Ph.Eur. 5 mg The Secretagogue (Micro-Dose): Triggers rapid, potent insulin release from the pancreas to control acute post-prandial (after-meal) glucose spikes. Pioglitazone (as Hydrochloride) USP/Ph.Eur. 15 mg The Sensitizer (Micro-Dose): Reverses deep cellular insulin resistance in skeletal muscle and adipose tissue. Metformin Hydrochloride USP/Ph.Eur. 500 mg (IR or ER) The Hepatic Anchor (Macro-Dose): Provides baseline suppression of liver glucose production. Frequently formulated in a sustained-release matrix to minimize severe GI side effects. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder (ER Polymer) / Lubricant (Engineered utilizing elite multi-stage geometric dilution to guarantee that the lethal 5mg micro-dose of Glibenclamide is flawlessly and evenly distributed throughout the massive 500mg Metformin matrix) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).
Glimepiride & Metformin Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Bilayered Tablets or Film Coated Tablets. The bilayered technology is often used to manage the different release profiles and physical characteristics of the two APIs.
Active Ingredient Strength (Standard) Therapeutic Role Glimepiride USP/BP/IP 1 mg / 2 mg Sulfonylurea (Insulin Secretagogue) Metformin HCl USP/BP/IP 500 mg / 1000 mg Biguanide (Insulin Sensitizer) Excipients Q.S. Povidone / Magnesium Stearate Stabilizing Core Matrix Glimepiride, Pioglitazone & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Common Strength Primary Clinical Function Metformin HCl (SR/IR) 500 mg / 1000 mg The Foundation: Reduces glucose production. Glimepiride 1 mg / 2 mg The Stimulator: Enhances insulin secretion. Pioglitazone 15 mg The Sensitizer: Fixes insulin resistance. Hydrocortisone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Scored Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micronized steroid payload.
Active Ingredient Strength Primary Clinical Function Hydrocortisone USP/Ph.Eur. 5 mg / 10 mg (Scored) Titration & Afternoon Standard: Highly precise, low-dose units engineered for pediatric CAH dosing and the critical “afternoon taper” in adult replacement therapy. Hydrocortisone USP/Ph.Eur. 20 mg (Scored) Morning Surge & Acute Flare Standard: High-efficacy dosing to replicate the natural morning cortisol spike, or for short-term suppression of acute severe allergic or inflammatory conditions. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate Diluent / Binder / Superdisintegrant / Lubricant (Engineered utilizing Micronized API—the steroid particles are milled to a microscopic size before blending to guarantee immediate, consistent gastric absorption, which is critical to avoid unpredictable hormone spikes) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict chronic, lifelong endocrinology dispensing regimens).
Linagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the highly hygroscopic combination.
Active Ingredient Strength Primary Clinical Function Linagliptin / Metformin HCl (IR) 2.5 mg / 500 mg
2.5 mg / 850 mg
2.5 mg / 1000 mgTwice-Daily Standard: Immediate-release units designed to be taken twice a day with meals to provide rapid, meal-time incretin spikes alongside baseline hepatic suppression. Linagliptin / Metformin HCl (ER) 5 mg / 1000 mg (ER) Once-Daily Premium Standard: High-efficacy Extended-Release therapy designed for ultimate patient compliance, delivering the full daily dose of Linagliptin while slowly trickling Metformin into the gut over 24 hours to prevent severe gastrointestinal side effects. Excipients Hypromellose (HPMC) / Copovidone / Microcrystalline Cellulose / Magnesium Stearate / Premium Moisture-Barrier Film ER Polymer / Binder / Diluent / Lubricant (Engineered utilizing elite Bilayer Rotary Presses to physically separate the delicate 2.5mg/5mg Linagliptin dose from the massive, moisture-drawing Metformin layer, preventing cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Linagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Film-Coated Tablet, packed exclusively in highly secure Alu-Alu blister strips to ensure the absolute chemical stability of the delicate API.
Active Ingredient Strength Primary Clinical Function Linagliptin USP/Ph.Eur. 5 mg The Universal Standard: A single, high-efficacy maintenance dose that applies to all adult patients, regardless of age, hepatic function, or severe renal impairment. Excipients Mannitol / Pregelatinized Starch / Copovidone / Magnesium Stearate / Premium Opadry Film Diluent / Disintegrant / Binder / Moisture-Barrier Coating (Engineered specifically without highly hygroscopic components to prevent moisture absorption, ensuring rapid disintegration and maximum bioavailability of the 5mg payload) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Medroxyprogesterone Acetate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micronized Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the delicate steroid molecule.
Active Ingredient Strength Primary Clinical Function Medroxyprogesterone Acetate USP/Ph.Eur. 2.5 mg / 5 mg HRT Maintenance Standard: Continuous or sequential low-dose therapy for the prevention of endometrial hyperplasia in postmenopausal women receiving estrogen. Medroxyprogesterone Acetate USP/Ph.Eur. 10 mg Acute Gynecology Standard: High-efficacy adult dosing for the rapid arrest of abnormal uterine bleeding and the induction of withdrawal bleeding in secondary amenorrhea. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Lubricant (Engineered specifically utilizing advanced micronized API to overcome the severe hydrophobicity of the steroid, ensuring maximum, predictable gastric absorption) *Pack Sizes: 10×10 Blisters or 14-Day Calendar Packs (Optimized specifically for strict cyclic or continuous gynecological dispensing regimens).
Methimazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the thionamide compound.
Active Ingredient Strength Primary Clinical Function Methimazole (Thiamazole) USP/Ph.Eur. 5 mg Maintenance / Titration Standard: Base therapeutic unit for precisely lowering doses as the patient approaches the euthyroid (normal) state, preventing drug-induced hypothyroidism. Methimazole (Thiamazole) USP/Ph.Eur. 10 mg Initial Suppression Standard: High-efficacy adult therapy for rapidly crashing toxic thyroid hormone levels during severe, active hyperthyroidism. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Odor-Masking Coating (Engineered specifically using strict geometric dilution to ensure the microscopic API dose is flawlessly distributed, and fi lm-coated to mask the compound’s inherent sulfurous taste) Methimazole Tablets
FreeTechnical & Logistics Specifications
HS Code: 3004.90.39 (Medicaments containing hormones or other products – Antithyroid)
CAS Number: 60-56-0 (Methimazole / Thiamazole)
Dosage Form: Uncoated or Film-Coated Tablet
Packaging: Alu-Alu or Alu-PVC Blisters. Protects the sensitive API from environmental humidity; our high-barrier packaging ensures 24-month stability in Zone IVb tropical climates.
Neomercazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly reactive thionamide molecule.
Active Ingredient Strength Primary Clinical Function Carbimazole Ph.Eur./BP 5 mg Maintenance / Titration Standard: Base therapeutic unit for the gradual tapering of therapy and long-term maintenance of euthyroidism. Carbimazole Ph.Eur./BP 10 mg / 20 mg Acute Initiation Standard: High-dose induction therapy to aggressively shut down severe, life-threatening thyrotoxicosis. Excipients Lactose Monohydrate / Maize Starch / Magnesium Stearate / Povidone K30 / Iron Oxide Yellow (for distinct clinical identification) Diluent / Binder / Lubricant (Engineered specifically for rapid, complete gastric dissolution to achieve peak methimazole blood levels within 1 to 2 hours) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict chronic endocrinology dispensing, as patients initiate on high doses and taper down over many months).
Repaglinide & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined formulation.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 1 mg / 2 mg Short-acting meglitinide for rapid post-prandial (after-meal) insulin stimulation. Metformin Hydrochloride USP/Ph.Eur. 500 mg Global Clinical Standard: Biguanide for hepatic glucose suppression and insulin sensitization. Excipients Microcrystalline Cellulose / Povidone K30 / Croscarmellose Sodium / Poloxamer / Magnesium Stearate Diluent / Binder / Superdisintegrant / Surfactant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Repaglinide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly sensitive meglitinide API.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 0.5 mg Base titration unit for treatment-naive patients or those with severe renal/hepatic impairment. Repaglinide USP/Ph.Eur. 1 mg / 2 mg Global Clinical Standard: Advanced maintenance doses for rapid post-prandial insulin stimulation. Excipients Microcrystalline Cellulose / Calcium Hydrogen Phosphate / Meglumine / Poloxamer / Magnesium Stearate Diluent / Stabilizer / Surfactant / Lubricant (Engineered for immediate gastric dissolution and ultra-fast systemic absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Saxagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Saxagliptin (as Hydrochloride) INN/Ph.Eur. 2.5 mg Target dose for patients with moderate/severe renal impairment or those taking strong CYP3A4 inhibitors. Saxagliptin (as Hydrochloride) INN/Ph.Eur. 5 mg Global Clinical Standard: Maximum adult daily dose for the maintenance of Type 2 Diabetes. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Binder / Superdisintegrant (Engineered for immediate gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens).
Stanozolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed in highly secure, moisture-resistant and child-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the active hormonal ingredient.
Active Ingredient Strength Primary Clinical Function Stanozolol USP/Ph.Eur. 2 mg Clinical Standard: Targeted oral anabolic therapy for the prophylaxis of Hereditary Angioedema (HAE). Excipients Lactose Monohydrate / Microcrystalline Cellulose / Magnesium Stearate / Starch Diluent / Binder / Lubricant (Engineered for immediate gastric dispersion and reliable systemic absorption) Teneligliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Bilayer or Matrix Sustained-Release Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly hygroscopic Metformin component.
Active Ingredient Strength Primary Clinical Function Teneligliptin Hydrobromide Hydrate INN 20 mg Immediate-release DPP-4 inhibition for rapid post-prandial (after-meal) glucose control. Metformin Hydrochloride BP/Ph.Eur. 500 mg (Sustained-Release) Continuous 24-hour hepatic glucose suppression and peripheral insulin sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release of Metformin) Teneligliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the active pharmaceutical ingredient across diverse tropical and high-humidity climates.
Active Ingredient Strength Primary Clinical Use Teneligliptin Hydrobromide Hydrate INN 20 mg Standard Global Dose: Once-daily therapy for glycemic control in Type 2 Diabetes. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for immediate gastric dissolution and rapid absorption) Vildagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Film-Coated Tablet (Available in Immediate or Bilayer Sustained-Release formats), packed strictly in high-barrier Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Vildagliptin is intensely sensitive to moisture degradation.
Active Ingredient Strength & Format Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg (Immediate Release Layer) Rapid dissolution to block DPP-4 and manage post-prandial incretin levels. Metformin Hydrochloride USP/BP 500 mg / 850 mg / 1000 mg (IR or SR) Provides continuous baseline hepatic glucose suppression and peripheral sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Titanium Dioxide SR Polymer Matrix / Diluent / Film-Coating (Engineered for precise kinetic release) Vildagliptin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed strictly in high-barrier Alu-Alu blister strips to guarantee absolute protection from moisture and environmental degradation.
Active Ingredient Strength Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg Standard Adult Dose for monotherapy or adjunctive combination therapy. Excipients Microcrystalline Cellulose / Anhydrous Lactose / Magnesium Stearate Diluent / Lubricant (Engineered for optimal compressibility and rapid gastric dispersion) Voglibose & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Bilayer Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Voglibose is highly sensitive to moisture degradation.
Active Ingredient Strength & Format Release Profile Function Voglibose USP/BP/JP 0.2 mg / 0.3 mg (Immediate Release Layer) Instantly dissolves in the gut to block carbohydrate absorption during the meal. Metformin Hydrochloride USP/BP 500 mg (Sustained Release Matrix) Slow-release polymer matrix providing continuous 24-hour hepatic suppression. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose SR Polymer Matrix / Diluent (Engineered to control precise dissolution rates) Voglibose Tablet
FreeVoglibose tablets are oral anti-diabetic medications primarily composed of the active ingredient Voglibose, a synthetic alpha-glucosidase inhibitor. They are typically available in strengths of 0.2 mg or 0.3 mg.
